Open AccessLongitudinal Immune Response to 3 Doses of Messenger RNA Vaccine Against Coronavirus Disease 2019 (COVID-19) in Pediatric Patients Receiving Chemotherapy for Cancer
Author(s) -
Thomas Lehrnbecher,
Ulrich Sack,
Carsten Speckmann,
Andreas H. Groll,
Andreas Boldt,
Benjamin Siebald,
Simone Hettmer,
Eva-Maria Demmerath,
Judith Reemtsma,
Barbara Schenk,
Sandra Ciesek,
JanHenning Klusmann,
Christian Jassoy,
Sebastian Hoehl
Publication year - 2022
Publication title -
clinical infectious diseases
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 3.44
H-Index - 336
eISSN - 1537-6591
pISSN - 1058-4838
DOI - 10.1093/cid/ciac570
Subject(s) - medicine , chemotherapy , immune system , clinical trial , immunology , immunity , induction chemotherapy , cancer , cellular immunity , disease
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom